Tyber Medical received FDA 510(k) clearance of its headed and snap-off screws systems with configurations incorporating the proprietary BioTy™ modified surface treatment. The systems are immediately available to the company’s private label partners.
These screws are indicated for use in the extremities for bone reconstruction, osteotomies, arthrodesis, joint fusion, fracture repair and fixation of bones appropriate for the size of the device.
Tyber Medical’s portfolio now includes over 46,000 different product configurations contained across 39 different product lines, all of which are available through Tyber Medical private label partnerships.
Mr. Jeff Tyber, President and CEO of Tyber Medical, is a participant in the OMTEC 2016 panel on Device Innovation of the Future. This session will convene on June 16 in Chicago, Illinois at 11:00 a.m. CT.
Tyber Medical received FDA 510(k) clearance of its headed and snap-off screws systems with configurations incorporating the proprietary BioTy™ modified surface treatment. The systems are immediately available to the company's private label partners.
These screws are indicated for use in the extremities for bone reconstruction, osteotomies,...
Tyber Medical received FDA 510(k) clearance of its headed and snap-off screws systems with configurations incorporating the proprietary BioTy™ modified surface treatment. The systems are immediately available to the company’s private label partners.
These screws are indicated for use in the extremities for bone reconstruction, osteotomies, arthrodesis, joint fusion, fracture repair and fixation of bones appropriate for the size of the device.
Tyber Medical’s portfolio now includes over 46,000 different product configurations contained across 39 different product lines, all of which are available through Tyber Medical private label partnerships.
Mr. Jeff Tyber, President and CEO of Tyber Medical, is a participant in the OMTEC 2016 panel on Device Innovation of the Future. This session will convene on June 16 in Chicago, Illinois at 11:00 a.m. CT.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
